June 2020

Alicorn completes US$6m co-investment in Glassbox Digital

Alicorn & Co. (Alicorn) has completed a US$6m co-investment in Glassbox Digital, a UK-based enterprise software company that recently closed a US$40m Series C round.

Alicorn is Arowana’s recently launched global venture capital arm and is headquartered in London. The new standalone entity is focussing on proprietary opportunities in enterprise software, cybersecurity, and data analytics. The current landscape has brought forward a period of digital transformation and with it, opportunities to invest in companies ready to take advantage.

Alicorn’s investment strategy is unique in that it focusses on exclusive primary funding rounds as well as providing secondary liquidity to shareholders of late growth stage technology companies. Alicorn works with these companies, their existing venture capital investors, and other stakeholders to participate in bespoke funding rounds and facilitate investments to solve liquidity requirements. The firm’s team span four continents with venture and advisory partners in the UK, Israel, the US, Singapore, and Australia.

About Alicorn

Established by Arowana, Alicorn is a global venture capital group that undertakes proprietary, exclusive primary and secondary investments in best-in-class, fast-growing technology companies in the enterprise software, cybersecurity, and data analytics sectors.

About Arowana

Arowana is a global B Corporation that has operating companies and investments across the UK, Southeast Asia, Australia, and the US. Established in 2007, Arowana’s purpose is to grow people, grow companies, and grow value.

Read More

December 2024

VivoPower’s Caret Digital to activate Dogecoin mining operations, with revenue and profitable cashflow generation by early January 2025

September 2024

Announcement on Intueri Class Action Lawsuit

September 2024

VivoPower announces strategic merger heads of agreement with FAST at a pro-forma combined equity value of US$1.13bn

September 2024

VivoPower secures Mpox diagnostic tests distribution heads of agreement for Singapore, Hong Kong and Australia with Sansure Biotech

August 2024

Tembo E-LV Executes a Definitive Business Combination Agreement with CCTS for a Combined Enterprise Value of US$904 Million

July 2024

VivoPower’s Tembo Extends Heads of Agreement Exclusivity for US$838M Merger with CCTS

1 2 3 23
crossmenu